Jeffrey Points - Cardiovascular Systems Chief Officer
Executive
Mr. Jeffrey Points is Chief Financial Officer of the company. Mr. Points joined us in September 2007 as Corporationrationrate Controller, became Senior Director and Controller in July 2013, Corporationrationrate Controller and Treasurer in January 2015, Vice President, Corporationrationrate Controller and Treasurer in May 2017 and was promoted to Chief Financial Officer in February 2018. From July 2005 to September 2007, Mr. Points was Assistant Controller at Empi, a manufacturer and provider of noninvasive medical products for pain management and physical rehabilitation. From January 1998 to July 2005, Mr. Points held various leadership positions at CliftonLarsonAllen, a national public accounting firm. Mr. Points also serves as a member of the Board of Directors for The Phoenix Residence, Inc. since 2018.
| Age | 45 |
| Tenure | 7 years |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Stephen JD | Sight Sciences | N/A | |
| Manohar Raheja | Sight Sciences | 66 | |
| Anthony Recupero | Si Bone | 66 | |
| Suzanne Armstrong | Orthofix Medical | N/A | |
| Mark Karshner | Orthopediatrics Corp | N/A | |
| RN MBA | CVRx Inc | N/A | |
| Jill Mayer | MaxCyte | N/A | |
| Julie Andrews | Orthofix Medical | 54 | |
| Reay MD | Sight Sciences | N/A | |
| Jennifer Sipple | Outset Medical | N/A | |
| Scot JD | Treace Medical Concepts | 49 | |
| Ronald CPA | MaxCyte | 67 | |
| Roberto Mezerville | Establishment Labs Holdings | 44 | |
| David Caraway | Nevro Corp | 63 | |
| John Harris | Integer Holdings Corp | 65 | |
| Greg Siller | Nevro Corp | 44 | |
| Jonathan Friedman | Paragon 28 | 53 | |
| MSc MD | CVRx Inc | N/A | |
| Matthew Brinckman | Paragon 28 | N/A | |
| Michael Wysocki | Rapid Micro Biosystems | N/A | |
| Sean Scanlan | Treace Medical Concepts | 42 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Freed, VP Marketing | ||
| Stephen Rempe, Chief Officer | ||
| Jeffrey MD, Chief Officer | ||
| Peter Hirshman, VP Operations | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Jeffrey Points, Chief Officer | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| John Nielsen, VP Communications |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |